These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 39205577)
1. Evaluation of the Plasma Expression Levels of miR-21 and miR-145 as Potential Non-Invasive Biomarkers for Early Detection of Colorectal Cancer. Rattan Negi R; Rana SV; Gupta V; Gupta R; Dhawan DK Asian Pac J Cancer Prev; 2024 Aug; 25(8):2797-2804. PubMed ID: 39205577 [TBL] [Abstract][Full Text] [Related]
2. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
3. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530 [TBL] [Abstract][Full Text] [Related]
4. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
5. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. Luo X; Stock C; Burwinkel B; Brenner H PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963 [TBL] [Abstract][Full Text] [Related]
6. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
8. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer. Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863 [TBL] [Abstract][Full Text] [Related]
9. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209 [TBL] [Abstract][Full Text] [Related]
11. Plasma miRNA can detect colorectal cancer, but how early? Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205 [TBL] [Abstract][Full Text] [Related]
12. Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients. Farouk S; Khairy A; Salem AM; Soliman AF; Bader El Din NG Genet Test Mol Biomarkers; 2020 Dec; 24(12):825-834. PubMed ID: 33290159 [No Abstract] [Full Text] [Related]
13. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
14. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
15. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients. Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365 [TBL] [Abstract][Full Text] [Related]
16. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
17. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer. Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735 [TBL] [Abstract][Full Text] [Related]
18. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. Xu L; Li M; Wang M; Yan D; Feng G; An G BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of miR-92a, -143, and -145 expression levels in patients with colorectal adenocarcinoma from Romania. Brînzan C; Aşchie M; Cozaru G; Dumitru E; Mitroi A Medicine (Baltimore); 2020 Aug; 99(35):e21895. PubMed ID: 32871920 [TBL] [Abstract][Full Text] [Related]
20. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer. Zou G; Wang R; Wang M Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]